secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001171843-25-007344
Event type: earnings
Sentiment:  negative
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology Q3 EPS loss $(107.24); records $74.4M derivative liability on ATH token strategy
--------------------------------------------------------------------------------

- Revenue of $3,618 virtually unchanged from $3,907 in Q3 2024; cash fell to $181,667 from $611,822 at Dec 31, 2024.
- GAAP net loss per share from continuing operations of $(107.24), including a $74.4M loss on derivative instruments.
- Held 5.70 billion ATH tokens as of Nov 10, 2025; market value ~$152.8M, with 3.7B locked and 2.0B unlocked.
- Received ~$50.8M cash proceeds and ~$292.7M in-kind ATH notional from two private placements under new digital asset treasury strategy.
- Appointed Shawn Matthews (former CEO of Cantor Fitzgerald) to Board of Directors; strategic collaboration with Every Cure announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325007344/0001171843-25-007344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325007344/f8k_111425.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer